The common use of Fen-Phen diet drugs Redux and
Pondimin have led to an unprecedented number of new Primary
Pulmonary Hypertension (PPH) cases over the last 10 years.
The FDA removed these popular diet drugs from the
marketplace in 1997 because of links to Primary Pulmonary
Hypertension and other heart conditions such as mistral and
aortic valve regurgitation.
The following medical conditions are consistent with
conditions caused by Fen Phen, Redux or Pondimin:
-
Symptoms of Primary Pulmonary Hypertension
-
Progressive shortness of breath with activity
-
Hyperventilation
-
Chest pain under the sternum
-
Weakness
-
Fatigue
-
Fainting
-
Lightheadedness with upright posture
-
Dizziness
-
Coughing up blood
Pulmonary hypertension develops as a response to increased
resistance to blood flow. Diffuse narrowing of the pulmonary
arterioles occurs. The right side of the heart becomes
enlarged due to the increased work load of pumping blood
against this resistance. Eventually, progressive heart
failure develops.
Fen phen
was a combination drug mixture of Pondimin or Redux with
phentermine (an amphetamine-like drug) and was designed to
promote weight loss. Both Redux (dexfenfluramine) and
Pondimin (fenfluramine), the "Fen"s in the combination, were
diet drugs manufactured by American Home Products ("AHP").
They were designed to suppress the appetite by altering
brain levels of serotonin, but both were withdrawn
simultaneously from the market in September of 1997 when
both were linked to the occurrence of serious cardiac
valvular disease, and primary pulmonary hypertension
Pondimin and
Redux were two of the most widely prescribed diet drugs
in the U.S. In 1996, sales of Pondimin and Redux totaled
well over 20 million prescriptions. According to company
estimates, 4 million people have used Pondimin and
another 2 million have used Redux.
The Law Offices of James P. Howe is a Rhode Island
Medical Malpractice Law Firm who commits the necessary resources to fight any
pharmaceutical corporation including the manufacturers of
Fen Phen, Redux and
Pondimen and all other diet drugs.
We work on a
contingency fee basis. A contingency fee means we only
obtain a fee if we make a recovery. If we do not win the
case or make a recovery our clients owe us nothing for our
time, costs or expenses.
With many decades of combined experience, the Law Offices of
James P. Howe, and our highly experienced staff of trial
attorneys, paralegals, investigators and law clerks have the
expertise and ample resources to successfully research,
investigate and litigate all of our clients Primary
Pulmonary Hypertension claims. We promise every client that
their claim will be reviewed diligently and carefully. If we
take a case, we will work extremely hard to obtain the best
possible result. We can help you immediately. All e-mail and
form submissions will be responded to by a qualified member
of our firm within 24 hours.
Contact us
today by
Email
or call us today at (401) 788-0600 to speak with
someone from our firm..
|